DexCom, Inc. - Common Stock (NQ:DXCM)

59.72 +0.11 (+0.18%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 13, 2025 Add to My Watchlist

Price and Volume

Volume	6,729,906
Open	59.20
Bid (Size)	59.00 (100)
Ask (Size)	60.00 (200)
Prev. Close	59.61
Today's Range	59.20 - 60.85
52wk Range	54.11 - 93.25
Shares Outstanding	390,000,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

Today 15:31 EST

From The Rosen Law Firm PA

Via GlobeNewswire

DXCM Class Action Lawsuit: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors That a Securities Fraud Class Action Lawsuit Has Been Filed

Today 11:46 EST

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Performance

YTD	-23.9%	-23.9%
1 Month	-8.4%	-8.4%
3 Month	-25.3%	-25.3%
6 Month	-31.0%	-31.0%
1 Year	-19.7%	-19.7%

More News

DXCM Class Action Lawsuit: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors That a Securities Fraud Class Action Lawsuit Has Been Filed

Today 11:46 EST

Via TheNewswire.com

Winners And Losers Of Q3: DexCom (NASDAQ:DXCM) Vs The Rest Of The Patient Monitoring Stocks

November 12, 2025

Via StockStory

Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 26, 2025 - DXCM

November 12, 2025

Via NewMediaWire

Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of December 26, 2025 - DXCM

November 12, 2025

Via TheNewswire.com

DexCom Stock Just Fell to a 5-Year Low. Is It a No-Brainer Buy at This Price? ↗

November 12, 2025

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom, Synopsys, CarMax, and Fiserv and Encourages Investors to Contact the Firm

November 11, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Bio-Techne, Tandem Diabetes, Align Technology, DexCom, and Teleflex Shares Skyrocket, What You Need To Know

November 11, 2025

Via StockStory

Exploring the top movers within the S&P500 index during today's session. ↗

November 11, 2025

Via Chartmill

Wall Street Pauses, Silver Reclaims $50 With Shutdown End In Sight: What's Moving Markets Tuesday? ↗

November 11, 2025

Via Benzinga

What's going on in today's session: S&P500 movers ↗

November 11, 2025

Via Chartmill

DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm

November 11, 2025

From Schall Law

Via GlobeNewswire

DexCom, Inc. (DXCM) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of Securities Fraud Class Action Lawsuit

November 11, 2025

Via TheNewswire.com

DexCom, Inc. (DXCM) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of Securities Fraud Class Action Lawsuit

November 11, 2025

Via NewMediaWire

1 Spectacular Growth Stock Down 20% to Buy Right Now, According to Wall Street ↗

November 11, 2025

Via The Motley Fool

Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM

November 11, 2025

Via NewMediaWire

Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before December 26, 2025 to Discuss Your Rights - DXCM

November 11, 2025

Via TheNewswire.com

DexCom Inc (NASDAQ:DXCM) Embodies the Affordable Growth Investment Method ↗

November 11, 2025

Via Chartmill

2 Volatile Stocks with Impressive Fundamentals and 1 Facing Headwinds

November 10, 2025

Via StockStory

DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

November 10, 2025

Via TheNewswire.com

DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP

November 10, 2025

Via NewMediaWire

Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the “Company”) (NASDAQ: DXCM) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

November 10, 2025

From Lowey Dannenberg, P.C.

Via GlobeNewswire

Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact Levi & Korsinsky

November 10, 2025

Via NewMediaWire

Class Action Filed Against DexCom, Inc. (DXCM) Seeking Recovery for Investors - Contact Levi & Korsinsky

November 10, 2025

Via TheNewswire.com

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?

Yes, DexCom, Inc. - Common Stock is publicly traded.

What exchange does DexCom, Inc. - Common Stock trade on?

DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for DexCom, Inc. - Common Stock?

The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market

What is the current price of DexCom, Inc. - Common Stock?

The current price of DexCom, Inc. - Common Stock is 59.72

When was DexCom, Inc. - Common Stock last traded?

The last trade of DexCom, Inc. - Common Stock was at 11/13/25 04:00 PM ET

What is the market capitalization of DexCom, Inc. - Common Stock?

The market capitalization of DexCom, Inc. - Common Stock is 23.29B

How many shares of DexCom, Inc. - Common Stock are outstanding?

DexCom, Inc. - Common Stock has 23B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.